Sectors

HCM
HUTCHMED (China) Limited
12.47
1 x 12.39
1 x 12.49
bid
ask
-
0.08
0.64%
1 @ 04:00 PM
12.47 +0.00 (0.00%)
Ytd-6.45%
1y-19.44%
12.40
day range
12.55
9.77
52 week range
18.30
Open12.55Prev Close12.55Low12.40High12.55Mkt Cap2.18B
Vol16.64KAvg Vol52.35KEPS2.67P/E4.67Forward P/E54.81
Beta0.44Short Ratio3.80Inst. Own2.57%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-3050-d Avg11.06200-d Avg13.471yr Est21.49

HCM News

Oracle Adds New Fusion Agentic Applications and AI Agents to Help Organizations Improve Talent Management
gurufocus.com
Oracle Adds New Fusion Agentic Applications and AI Agents to Help Organizations Improve Talent Manag

Oracle Adds New Fusion Agentic Applications and AI Agents to Help Organizations Improve Talent Manag

HUTCHMED (China) Limited (HCM) Q2 2026 Earnings Call Transcript
seekingalpha.com
HUTCHMED (China) Limited (HCM) Q2 2026 Earnings Call Transcript

HUTCHMED (China) Limited (HCM) Q2 2026 Earnings Call Transcript

HUTCHMED H1 Earnings Call Highlights
marketbeat.com
HUTCHMED H1 Earnings Call Highlights

HUTCHMED NASDAQ: HCM reported first-half 2026 oncology revenue of $162 million, including $121 milli

Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)
globenewswire.com
Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in

Study substantially exceeded enrollment target of 500 patients Topline results anticipated in Q1 202

Hutchmed: Bullish On Their Commercial Prospects And Pipeline Catalysts
seekingalpha.com
Hutchmed: Bullish On Their Commercial Prospects And Pipeline Catalysts

Hutchmed basically combines a growing oncology franchise with late-stage immunology assets and an ea

AI Solution Providers Shift From AI Features to AI-Enabled Execution
gurufocus.com
AI Solution Providers Shift From AI Features to AI-Enabled Execution

[url="]The Hackett Group, Inc.[/url] (NASDAQ: HCKT), an ROI-led AI transformation firm, today releas

HUTCHMED Announces NMPA Approval for ORPATHYS® for the treatment of Gastric Cancer Patients with MET Amplification
globenewswire.com
HUTCHMED Announces NMPA Approval for ORPATHYS® for the treatment of Gastric Cancer Patients with MET

First selective MET inhibitor approved for patients with MET-amplified advanced gastric cancer or ga

HUTCHMED to Announce 2026 Half-Year Financial Results
globenewswire.com
HUTCHMED to Announce 2026 Half-Year Financial Results

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 30, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Li

Buy These 3 HCM Software Solution Stocks to Tap Short-Term Potential
zacks.com
Buy These 3 HCM Software Solution Stocks to Tap Short-Term Potential

AI-driven hiring and HR automation are reshaping HCM software, with three companies, namely, PAYC, P

Syndio Acquires Embrace.ai
businesswire.com
Syndio Acquires Embrace.ai

SEATTLE--(BUSINESS WIRE)--Syndio, the Decision Intelligence for Pay company, today announced the acq

isolved Introduces Autonomous AI Agents Built to Own HR Outcomes — Brings Unified HCM Platform to Anthropic's Claude Connectors Directory
globenewswire.com
isolved Introduces Autonomous AI Agents Built to Own HR Outcomes — Brings Unified HCM Platform to An

LAS VEGAS, June 16, 2026 (GLOBE NEWSWIRE) -- Connect For Partners -- isolved ® today unveiled the fi

Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)
prnewswire.com
Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with ED

– No relationship observed between EDG-7500 exposure and LVEF; no LVEF reductions below 50% – – Cons

isolved Honors Top-Performing Partners at Annual Connect for Partners Event
globenewswire.com
isolved Honors Top-Performing Partners at Annual Connect for Partners Event

LAS VEGAS, June 15, 2026 (GLOBE NEWSWIRE) -- Connect for Partners – isolved®, a provider of human ca

isolved Introduces New Strategic Marketplace Partners at Connect 2026, Extending People Cloud™ Capabilities for Employers and Employees
globenewswire.com
isolved Introduces New Strategic Marketplace Partners at Connect 2026, Extending People Cloud™ Capab

LAS VEGAS, June 15, 2026 (GLOBE NEWSWIRE) -- Connect For Partners – isolved, a provider of human cap

Paychex Recognized as a Top WorkTech Company by TIME
globenewswire.com
Paychex Recognized as a Top WorkTech Company by TIME

Paychex named a leading HCM provider to TIME's America's Top WorkTech Companies 2026 List List ident

HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia Presented at EHA 2026 Congress
globenewswire.com
HUTCHMED Highlights Sovleplenib ESLIM-02 Phase III Data in Warm Antibody Autoimmune Hemolytic Anemia

— Sovleplenib demonstrated rapid and durable hemoglobin response with favorable safety profile — —Th

U.S. Office of Personnel Management Selects Oracle to Power Federal Workforce Modernization
gurufocus.com
U.S. Office of Personnel Management Selects Oracle to Power Federal Workforce Modernization

U.S. Office of Personnel Management Selects Oracle to Power Federal Workforce Modernization PR Newsw

Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms
globenewswire.com
Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM

All Evaluable Patients Achieved Improvements in Multiple Hallmarks of  MYBPC3-Associated HCM Benefit

Tenaya Therapeutics to Announce New Interim Data from MyPEAK™-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated HCM on Wednesday, June 3, 2026
globenewswire.com
Tenaya Therapeutics to Announce New Interim Data from MyPEAK™-1 Phase 1b/2 Trial of TN-201 for Adult

SOUTH SAN FRANCISCO, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TN

HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting
globenewswire.com
HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting

HONG KONG and FLORHAM PARK, N.J., May 22, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHM

Innovent and HUTCHMED Jointly Announce NMPA Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma
prnewswire.com
Innovent and HUTCHMED Jointly Announce NMPA Approval for TYVYT® (Sintilimab Injection) in Combinatio

Reduced risk of disease progression or death by 63%, with median PFS of 22.2 months in the FRUSICA-2

Earnings Scheduled For March 5, 2026
benzinga.com
Earnings Scheduled For March 5, 2026

IBEX, Tesla, IonQ, Warner Bros. Discovery And Other Big Stocks Moving Higher On Friday
benzinga.com
IBEX, Tesla, IonQ, Warner Bros. Discovery And Other Big Stocks Moving Higher On Friday

benzinga.com
Earnings Scheduled For August 7, 2025

benzinga.com
Earnings Scheduled For March 19, 2025

benzinga.com
Earnings Scheduled For February 28, 2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

benzinga.com
Earnings Scheduled For July 31, 2023

Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss

benzinga.com
Earnings Scheduled For February 28, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for

benzinga.com
Why Hempacco Are Trading Lower By 58%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers SeqLL Inc. (NASDAQ: SQL) shares jumped 120% to $1.85 after dropping around 39% on Thursda

benzinga.com
Lyft, BARK And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s p

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 413 companies reached new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  During Wednesday's trading, 517 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 838 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 404 stocks made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 215 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 1043 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday, 351 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

    On Monday, 671 companies achieved new lows for the year.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday, 166 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

    On Monday, 524 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

    On Friday, 368 stocks hit new 52-week lows.

benzinga.com
Earnings Scheduled For March 3, 2022

  Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly ea

benzinga.com
Stocks That Hit 52-Week Highs On Thursday

  Thursday's morning session saw 167 companies set new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

    This morning 132 companies reached new 52-week highs.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday

benzinga.com
60 Biggest Movers From Yesterday

60 Biggest Movers From Yesterday